form_type stringclasses 2 values | accession_number stringlengths 20 20 | filing_date stringdate 2017-03-15 11:31:43 2023-10-30 21:56:06 | quarter_ending stringclasses 448 values | company_name stringlengths 2 58 | text stringlengths 99 9.36k | entities listlengths 1 50 |
|---|---|---|---|---|---|---|
10-Q | 0000897101-18-000457 | 2018-05-08T11:59:58+00:00 | 20180331 | CYBEROPTICS CORP | 85% of the lower of the market price on the first or last day of the offering period. There were no shares issued under this plan in the three months ended March 31, 2018 or the three months ended March 31, 2017. | [
{
"Currency / Unit": "pure",
"End character": 2,
"End date for period": "2018-03-31",
"Label": "cybe:LowerOfMarketPriceFirstOrLastDayOfOfferingPercentage",
"Start character": 0,
"Start date for period": "2018-01-01",
"Value": 0.85
}
] |
10-Q | 0000897101-18-000457 | 2018-05-08T11:59:58+00:00 | 20180331 | CYBEROPTICS CORP | At March 31, 2018, the total unrecognized compensation cost related to outstanding non-vested stock based compensation arrangements was $1.7 million, and the related weighted average period over which this cost is expected to be recognized is 1.92 years. | [
{
"Currency / Unit": "USD",
"End character": 140,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"Start character": 137,
"Start date for period": "2018-03-31",
"Value": 1700000
}
] |
10-Q | 0000897101-18-000457 | 2018-05-08T11:59:58+00:00 | 20180331 | CYBEROPTICS CORP | $1.7 million, and the related weighted average period over which this cost is expected to be recognized is | [
{
"Currency / Unit": "USD",
"End character": 4,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"Start character": 1,
"Start date for period": "2018-03-31",
"Value": 1700000
}
] |
10-Q | 0000897101-18-000457 | 2018-05-08T11:59:58+00:00 | 20180331 | CYBEROPTICS CORP | Export sales as a percentage of total sales in the three months ended March 31, 2018 were 72%. Export sales as a percentage of total sales in the three months ended March 31, 2017 were 79%. Virtually all of our export sales are negotiated, invoiced and paid in U.S. dollars. Export sales by geographic area are summarized as follows: | [
{
"Currency / Unit": "pure",
"End character": 92,
"End date for period": "2018-03-31",
"Label": "cybe:RevenueExportSalesPercentage",
"Start character": 90,
"Start date for period": "2018-01-01",
"Value": 0.72
},
{
"Currency / Unit": "pure",
"End character": 187,
"End date for period": "2017-03-31",
"Label": "cybe:RevenueExportSalesPercentage",
"Start character": 185,
"Start date for period": "2017-01-01",
"Value": 0.79
}
] |
10-Q | 0000897101-18-000457 | 2018-05-08T11:59:58+00:00 | 20180331 | CYBEROPTICS CORP | In the three months ended March 31, 2018, sales to significant customer A accounted for 10% of our total revenue and sales to significant customer B accounted for 11% of our total revenue. As of March 31, 2018, accounts receivable from significant customer A were $947,000 and accounts receivable from significant customer B were $1.2 million. | [
{
"Currency / Unit": "pure",
"End character": 90,
"End date for period": "2018-03-31",
"Label": "us-gaap:ConcentrationRiskPercentage1",
"Start character": 88,
"Start date for period": "2018-01-01",
"Value": 0.1
},
{
"Currency / Unit": "pure",
"End character": 165,
"End date for period": "2018-03-31",
"Label": "us-gaap:ConcentrationRiskPercentage1",
"Start character": 163,
"Start date for period": "2018-01-01",
"Value": 0.11
},
{
"Currency / Unit": "USD",
"End character": 334,
"End date for period": "2018-03-31",
"Label": "us-gaap:AccountsReceivableNet",
"Start character": 331,
"Start date for period": "2018-03-31",
"Value": 1200000
}
] |
10-Q | 0000897101-18-000457 | 2018-05-08T11:59:58+00:00 | 20180331 | CYBEROPTICS CORP | We recorded an income tax benefit of $83,000 in the three months ended March 31, 2018, compared to an income tax benefit of $413,000 in the three months ended March 31, 2017. Our income tax benefit in the three months ended March 31, 2018, reflects an approximate 20% effective income tax rate and includes $35,000 of excess tax benefits from employee share-based payments. Our income tax benefit in the three months ended March 31, 2017 reflects an approximate 33% effective income tax rate and includes $208,000 of excess tax benefits from employee share-based payments. The decrease in our effective income tax rate in the three months ended March 31, 2018 is primarily due to the new lower tax rates reflected in the Tax Cuts and Jobs Act passed by the U.S. Congress in December 2017. | [
{
"Currency / Unit": "pure",
"End character": 171,
"End date for period": "2018-03-31",
"Label": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
"Start character": 169,
"Start date for period": "2018-01-01",
"Value": 0.2
},
{
"Currency / Unit": "pure",
"End character": 464,
"End date for period": "2017-03-31",
"Label": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
"Start character": 462,
"Start date for period": "2017-01-01",
"Value": 0.33
}
] |
10-Q | 0000897101-18-000457 | 2018-05-08T11:59:58+00:00 | 20180331 | CYBEROPTICS CORP | Our Board of Directors has authorized a $3.0 million share repurchase program, of which $2.8 million remains available for future share repurchases. The common stock may be acquired from time to time in open market transactions, block purchases and other transactions complying with the Securities and Exchange Commission’s Rule 10b-18. The share repurchase program will terminate on September 30, 2018. During the three months ended March 31, 2018, no shares were repurchased under this program. | [
{
"Currency / Unit": "USD",
"End character": 44,
"End date for period": "2017-10-31",
"Label": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
"Start character": 41,
"Start date for period": "2017-10-31",
"Value": 3000000
},
{
"Currency / Unit": "USD",
"End character": 92,
"End date for period": "2018-03-31",
"Label": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
"Start character": 89,
"Start date for period": "2018-03-31",
"Value": 2800000
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | As of April 30, 2018, there were approximately 32,551,004 shares of the registrant's Class A common stock and 10,179,371 shares of the registrant's Class B common stock outstanding. | [
{
"Currency / Unit": "shares",
"End character": 57,
"End date for period": "2018-04-30",
"Label": "dei:EntityCommonStockSharesOutstanding",
"Start character": 47,
"Start date for period": "2018-04-30",
"Value": 32551004
},
{
"Currency / Unit": "shares",
"End character": 120,
"End date for period": "2018-04-30",
"Label": "dei:EntityCommonStockSharesOutstanding",
"Start character": 110,
"Start date for period": "2018-04-30",
"Value": 10179371
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | As of March 31, 2018, 550,242 shares of Class A common stock were available for grant under the 2014 Plan. | [
{
"Currency / Unit": "shares",
"End character": 29,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
"Start character": 22,
"Start date for period": "2018-03-31",
"Value": 550242
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | Our ESPP became effective on June 13, 2017. Under the ESPP, eligible employees are granted options to purchase shares of Class A common stock at the lower of 85% of the fair market value of the stock at the time of grant or 85% of the fair market value at the time of exercise. Options to purchase shares are granted twice yearly on or about January 15 and July 15 and are exercisable on or about the succeeding July 14 and January 14, respectively, of each year. As of March 31, 2018, 4,920,003 shares of Class A common stock were available for issuance under the ESPP. No participant may purchase more than $12,500 worth of common stock in a six-month offering period. The ESPP’s initial offering period began in July 2017. Accordingly, 79,997 shares of common stock had been purchased or distributed pursuant to the ESPP as of March 31, 2018. | [
{
"Currency / Unit": "pure",
"End character": 160,
"End date for period": "2017-06-13",
"Label": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
"Start character": 158,
"Start date for period": "2017-06-13",
"Value": 0.85
},
{
"Currency / Unit": "pure",
"End character": 226,
"End date for period": "2017-06-13",
"Label": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
"Start character": 224,
"Start date for period": "2017-06-13",
"Value": 0.85
},
{
"Currency / Unit": "shares",
"End character": 495,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
"Start character": 486,
"Start date for period": "2018-03-31",
"Value": 4920003
},
{
"Currency / Unit": "USD",
"End character": 616,
"End date for period": "2017-06-13",
"Label": "wk:SharebasedCompensationArrangementbySharebasedPaymentAwardMaximumPurchaseValueDuringOfferingPeriodPerEmployee",
"Start character": 610,
"Start date for period": "2017-06-13",
"Value": 12500
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | Options to purchase Class A common stock generally vest over a three- or four-year period and are generally granted for a term of ten years. The total intrinsic value of options exercised during the three months ended March 31, 2018 and 2017 was $3.6 million and $1.0 million, respectively. | [
{
"Currency / Unit": "USD",
"End character": 250,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
"Start character": 247,
"Start date for period": "2018-01-01",
"Value": 3600000
},
{
"Currency / Unit": "USD",
"End character": 267,
"End date for period": "2017-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
"Start character": 264,
"Start date for period": "2017-01-01",
"Value": 1000000
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | We have granted restricted stock awards to our executive officers that vest in three equal annual installments from the date of grant. The recipient of an award of restricted stock under the Plan may vote and receive dividends on the shares of restricted stock covered by the award. The fair value for restricted stock awards is calculated based on the stock price on the date of grant. The total fair value of restricted stock awards vested during the three months ended March 31, 2018 and 2017 was approximately $2.2 million and $2.4 million, respectively. | [
{
"Currency / Unit": "USD",
"End character": 518,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
"Start character": 515,
"Start date for period": "2018-01-01",
"Value": 2200000
},
{
"Currency / Unit": "USD",
"End character": 535,
"End date for period": "2017-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
"Start character": 532,
"Start date for period": "2017-01-01",
"Value": 2400000
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | Compensation expense associated with unvested restricted stock awards is recognized on a straight-line basis over the vesting period. At March 31, 2018, there was no unrecognized compensation expense related to restricted stock awards. | [
{
"Currency / Unit": "USD",
"End character": 165,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
"Start character": 163,
"Start date for period": "2018-03-31",
"Value": 0
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | Restricted stock units granted to employees generally vest over a three- or four-year period in equal, annual installments, and restricted stock units granted to non-employee members of our Board of Directors generally have one-year cliff vesting from the date of grant. The recipient of a restricted stock unit award under the Plan will have no rights as a stockholder until share certificates are issued by us, but, at the discretion of our Compensation Committee, has the right to receive a dividend equivalent payment in the form of additional restricted stock units. Additionally, until the shares are issued, they have no voting rights and may not be bought or sold. The fair value for restricted stock units is calculated based on the stock price on the date of grant. The total fair value of restricted stock units vested during the three months ended March 31, 2018 and 2017 was approximately $3.0 million and $1.6 million, respectively. | [
{
"Currency / Unit": "USD",
"End character": 906,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
"Start character": 903,
"Start date for period": "2018-01-01",
"Value": 3000000
},
{
"Currency / Unit": "USD",
"End character": 923,
"End date for period": "2017-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
"Start character": 920,
"Start date for period": "2017-01-01",
"Value": 1600000
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | Compensation expense associated with unvested restricted stock units is recognized on a straight-line basis over the vesting period. At March 31, 2018, there was approximately $36.7 million of total unrecognized compensation expense related to restricted stock units, which is expected to be recognized over a weighted-average period of 2.7 years. | [
{
"Currency / Unit": "USD",
"End character": 181,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
"Start character": 177,
"Start date for period": "2018-03-31",
"Value": 36700000
}
] |
10-Q | 0001445305-18-000079 | 2018-05-02T16:21:52+00:00 | 20180331 | WORKIVA INC | $42.5 million of revenue recognized during the three months ended March 31, 2018 was included in the deferred revenue balance at the beginning of the period. | [
{
"Currency / Unit": "USD",
"End character": 5,
"End date for period": "2018-03-31",
"Label": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
"Start character": 1,
"Start date for period": "2018-01-01",
"Value": 42500000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | We classify cash as restricted when the cash is unavailable for withdrawal or usage for general operations. Our restricted cash represents cash collateral to one | [
{
"Currency / Unit": "intx:bank",
"End character": 161,
"End date for period": "2018-03-31",
"Label": "intx:NumberOfCommercialBanksRequiringCashCollateral",
"Start character": 158,
"Start date for period": "2018-01-01",
"Value": 1
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | As of March 31, 2018, goodwill of $347 thousand resided in our Insurance and Other Consumer Services reporting unit and goodwill of $9.4 million | [
{
"Currency / Unit": "USD",
"End character": 39,
"End date for period": "2018-03-31",
"Label": "us-gaap:Goodwill",
"Start character": 36,
"Start date for period": "2018-03-31",
"Value": 347000
},
{
"Currency / Unit": "USD",
"End character": 137,
"End date for period": "2018-03-31",
"Label": "us-gaap:Goodwill",
"Start character": 134,
"Start date for period": "2018-03-31",
"Value": 9400000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | Under the New Credit Agreement, we are currently prohibited from declaring and paying dividends and therefore, the dividend yield was zero. | [
{
"Currency / Unit": "pure",
"End character": 138,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
"Start character": 134,
"Start date for period": "2018-01-01",
"Value": 0
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | The expected volatility of options granted was estimated based upon our historical share price volatility based on the expected term of the underlying grants, or approximately 51%. | [
{
"Currency / Unit": "pure",
"End character": 178,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
"Start character": 176,
"Start date for period": "2018-01-01",
"Value": 0.51
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | The yield on actively traded non-inflation indexed U.S. Treasury notes was used to extrapolate an average risk-free interest rate based on the expected term of the underlying grants, or approximately 2.7%. | [
{
"Currency / Unit": "pure",
"End character": 203,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
"Start character": 200,
"Start date for period": "2018-01-01",
"Value": 0.027
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | As a result of our comprehensive assessment, we recorded a cumulative adjustment of approximately $1.6 million to the opening balance of retained earnings, which is primarily due to expensing direct-response advertising costs as well as immediately expensing certain incremental one-time commission costs. Given the continued valuation allowance on our net deferred taxes, the tax effect of these cumulative adjustments at adoption is also immaterial to the consolidated financial statements. | [
{
"Currency / Unit": "USD",
"End character": 102,
"End date for period": "2017-12-31",
"Label": "us-gaap:RetainedEarningsAccumulatedDeficit",
"Start character": 99,
"Start date for period": "2017-12-31",
"Value": 1600000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | With the exception of breach-response services, revenue is measured based on the stated consideration specified in the monthly renewable individual subscription contract. Subscription fees billed by our clients are generally billed directly to the subscriber’s credit card, mortgage bill or demand deposit accounts. Subscription fees billed by us are generally billed directly to the subscriber’s credit card except for arrangements under which subscription fees are paid to us by our clients on behalf of the subscriber. These payment mechanisms significantly reduce the risk of uncertain cash flows and a significant portion of our subscribers are billed in advance of fulfillment, which also mitigates uncertainty of cash flows. The prices to subscribers of various configurations of our non-breach services range generally from $4.99 to $25.00 | [
{
"Currency / Unit": "USD",
"End character": 837,
"End date for period": "2018-03-31",
"Label": "intx:MonthlySubscriptionPrice",
"Start character": 833,
"Start date for period": "2018-01-01",
"Value": 4.99
},
{
"Currency / Unit": "USD",
"End character": 847,
"End date for period": "2018-03-31",
"Label": "intx:MonthlySubscriptionPrice",
"Start character": 842,
"Start date for period": "2018-01-01",
"Value": 25
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | On July 31, 2017, we divested i4c to One Health Group, LLC (the "Purchaser"), pursuant to the terms and conditions of a membership interest purchase agreement (the "Purchase Agreement"). i4c conducted our Pet Health Monitoring business known as Voyce. The purchase price for the assets was equal to (i) the sum of $100 | [
{
"Currency / Unit": "USD",
"End character": 318,
"End date for period": "2017-07-31",
"Label": "us-gaap:ProceedsFromDivestitureOfBusinesses",
"Start character": 315,
"Start date for period": "2017-07-31",
"Value": 100
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | In 2016, our Board of Directors approved a plan to sell Captira, which comprised our Bail Bonds Industry Solutions segment. Effective January 31, 2017, we completed the sale of Captira for a nominal amount, which resulted in a loss on sale of $130 thousand and marked the conclusion of our operations in the Bail Bonds Industry Solutions segment. The disposal did not represent a strategic shift that would have a major effect on operations and financial results, and therefore, it is not classified as discontinued operations. For information on the operating results of the Bail Bonds Industry Solutions segment, please see "Item 2. — Management’s Discussion and Analysis of Financial Condition and Results of Operations." | [
{
"Currency / Unit": "USD",
"End character": 247,
"End date for period": "2017-01-31",
"Label": "us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
"Start character": 244,
"Start date for period": "2017-01-31",
"Value": -130000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | In March 2017, we executed an agreement to dispose of our Habits at Work business, the results of which are recorded in our Personal Information Services segment. Effective June 1, 2017, we completed the sale of Habits at Work for a nominal amount. The disposal did not represent a strategic shift that would have a major effect on operations and financial results, and therefore, it is not classified as discontinued operations. As part of the required evaluation under U.S. GAAP, we determined that the approximate fair value less costs to sell the businesses were significantly lower than the carrying value of the net assets. As a result, we recorded an impairment charge of $86 thousand related to Habits at Work for the three months ended March 31, 2017, which is included in impairment of intangibles and other assets in our condensed consolidated statements of operations. | [
{
"Currency / Unit": "USD",
"End character": 682,
"End date for period": "2017-03-31",
"Label": "us-gaap:AssetImpairmentCharges",
"Start character": 680,
"Start date for period": "2017-01-01",
"Value": 86000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | For the three months ended March 31, 2018 and 2017, options to purchase common stock, unvested restricted stock units and outstanding warrants totaling approximately 5.6 million shares and 3.4 million shares, respectively, were excluded from the computation of diluted loss per common share, as their effect would be anti-dilutive. These shares could dilute earnings per common share in the future. | [
{
"Currency / Unit": "shares",
"End character": 169,
"End date for period": "2018-03-31",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 166,
"Start date for period": "2018-01-01",
"Value": 5600000
},
{
"Currency / Unit": "shares",
"End character": 192,
"End date for period": "2017-03-31",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 189,
"Start date for period": "2017-01-01",
"Value": 3400000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | (1) In connection with the Replacement Warrant (as defined in Note 16), we received an additional payment of $700 thousand from PEAK6 Investments. In accordance with U.S. GAAP, we performed valuations immediately before and after the equity modification and concluded that the additional payment approximately represented the incremental fair value provided by the Replacement Warrant. For additional information, please see Note | [
{
"Currency / Unit": "USD",
"End character": 113,
"End date for period": "2018-03-31",
"Label": "us-gaap:ProceedsFromIssuanceOfWarrants",
"Start character": 110,
"Start date for period": "2018-01-01",
"Value": 700000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | In the three months ended March 31, 2018, we amortized $195 thousand related to costs to obtain, and there were no adverse changes which would cause the need for an impairment analysis. | [
{
"Currency / Unit": "USD",
"End character": 59,
"End date for period": "2018-03-31",
"Label": "us-gaap:CapitalizedContractCostAmortization",
"Start character": 56,
"Start date for period": "2018-01-01",
"Value": 195000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | In the three months ended March 31, 2018, we amortized $8 thousand related to costs to fulfill, and there were no adverse changes which would cause the need for an impairment analysis. | [
{
"Currency / Unit": "USD",
"End character": 40,
"End date for period": "2018-03-31",
"Label": "us-gaap:CapitalizedContractCostAmortization",
"Start character": 39,
"Start date for period": "2018-01-01",
"Value": 8000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | Intangible assets are amortized over a period of two to ten years. For the three months ended March 31, 2018 and 2017, we had an aggregate amortization expense of $49 thousand and $47 thousand, respectively, which was included in amortization expense in our condensed consolidated statements of operations. We estimate that we will have the following amortization expense for the future periods indicated below (in thousands): | [
{
"Currency / Unit": "USD",
"End character": 166,
"End date for period": "2018-03-31",
"Label": "us-gaap:AmortizationOfDeferredCharges",
"Start character": 164,
"Start date for period": "2018-01-01",
"Value": 49000
},
{
"Currency / Unit": "USD",
"End character": 183,
"End date for period": "2017-03-31",
"Label": "us-gaap:AmortizationOfDeferredCharges",
"Start character": 181,
"Start date for period": "2017-01-01",
"Value": 47000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | Rental expenses included in general and administrative expenses for the three months ended March 31, 2018 and 2017 were $664 thousand and $743 thousand, respectively. | [
{
"Currency / Unit": "USD",
"End character": 124,
"End date for period": "2018-03-31",
"Label": "us-gaap:OperatingLeasesRentExpenseNet",
"Start character": 121,
"Start date for period": "2018-01-01",
"Value": 664000
},
{
"Currency / Unit": "USD",
"End character": 142,
"End date for period": "2017-03-31",
"Label": "us-gaap:OperatingLeasesRentExpenseNet",
"Start character": 139,
"Start date for period": "2017-01-01",
"Value": 743000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | In March 2016, we and our subsidiaries entered into a credit agreement with Crystal Financial SPV LLC ("Prior Credit Agreement"). The Prior Credit Agreement provided for a $20.0 million senior secured term loan, which was fully funded at closing, with a maturity date of March 21, 2019 and interest at the greater of LIBOR plus 10% per annum or 10.5% per annum. | [
{
"Currency / Unit": "USD",
"End character": 177,
"End date for period": "2016-03-31",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 173,
"Start date for period": "2016-03-31",
"Value": 20000000
},
{
"Currency / Unit": "pure",
"End character": 330,
"End date for period": "2016-03-31",
"Label": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
"Start character": 328,
"Start date for period": "2016-03-01",
"Value": 0.1
},
{
"Currency / Unit": "pure",
"End character": 349,
"End date for period": "2016-03-31",
"Label": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
"Start character": 345,
"Start date for period": "2016-03-31",
"Value": 0.105
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | We used approximately $13.9 million of the net proceeds from the New Credit Agreement to repay in full the aggregate principal amount outstanding under the Prior Credit Agreement and to pay interest, prepayment penalties, transaction fees and expenses as a result of the termination. We used the remainder of the proceeds from the New Credit Agreement for general corporate purposes, including to increase subscriber acquisitions and continue our innovative product development. As a result of the refinancing, we recorded a loss on extinguishment of debt of $1.5 million in the year ended December 31, 2017, including interest, prepayment penalties, transaction fees and expenses totaling approximately $487 thousand as a result of the termination of the Prior Credit Agreement. | [
{
"Currency / Unit": "USD",
"End character": 27,
"End date for period": "2017-04-30",
"Label": "us-gaap:RepaymentsOfLongTermDebt",
"Start character": 23,
"Start date for period": "2017-04-01",
"Value": 13900000
},
{
"Currency / Unit": "USD",
"End character": 563,
"End date for period": "2017-12-31",
"Label": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
"Start character": 560,
"Start date for period": "2017-01-01",
"Value": -1500000
},
{
"Currency / Unit": "USD",
"End character": 708,
"End date for period": "2017-12-31",
"Label": "us-gaap:PaymentsOfDebtExtinguishmentCosts",
"Start character": 705,
"Start date for period": "2017-01-01",
"Value": 487000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | The New Credit Agreement requires the prepayment of the aggregate principal amount outstanding in an amount equal to 25% of our excess cash flow (as defined in the New Credit Agreement) for each fiscal year commencing with the fiscal year ending December 31, 2018 and continuing thereafter. Certain other events defined in the New Credit Agreement require prepayment of the aggregate principal amount of the term loan, including all or a portion of proceeds received from asset dispositions (except for proceeds from the sale of assets in our i4c subsidiary), casualty events, extraordinary receipts, and certain equity issuances. Once amounts borrowed have been paid or prepaid, they may not be reborrowed. | [
{
"Currency / Unit": "pure",
"End character": 119,
"End date for period": "2017-04-30",
"Label": "intx:DebtInstrumentPrepaymentofPrincipalAmountOutstandingasaPercentofExcessCashFlow",
"Start character": 117,
"Start date for period": "2017-04-30",
"Value": 0.25
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | As of March 31, 2018, $21.5 million was outstanding under the New Credit Agreement, which is presented net of unamortized debt issuance costs and debt discount totaling $710 thousand in our condensed consolidated balance sheets in accordance with U.S. GAAP. As of December 31, 2017, $21.5 million was outstanding under the New Credit Agreement, which is presented net of unamortized debt issuance costs and debt discount totaling $764 thousand in our condensed consolidated balance sheets. For information on the amendment executed on April 3, 2018, please see Note | [
{
"Currency / Unit": "USD",
"End character": 27,
"End date for period": "2018-03-31",
"Label": "us-gaap:LineOfCredit",
"Start character": 23,
"Start date for period": "2018-03-31",
"Value": 21500000
},
{
"Currency / Unit": "USD",
"End character": 173,
"End date for period": "2018-03-31",
"Label": "us-gaap:UnamortizedDebtIssuanceExpense",
"Start character": 170,
"Start date for period": "2018-03-31",
"Value": 710000
},
{
"Currency / Unit": "USD",
"End character": 288,
"End date for period": "2018-03-31",
"Label": "us-gaap:LineOfCredit",
"Start character": 284,
"Start date for period": "2018-03-31",
"Value": 21500000
},
{
"Currency / Unit": "USD",
"End character": 434,
"End date for period": "2017-12-31",
"Label": "us-gaap:ValuationAllowancesAndReservesBalance",
"Start character": 431,
"Start date for period": "2017-12-31",
"Value": 764000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | The New Credit Agreement contains certain customary covenants, including a requirement to maintain at all times a minimum cash on hand amount of the lesser of 20% or certain stated amounts of the total amount outstanding under the term loan, as set forth in the New Credit Agreement, and minimum EBITDA requirements. As of March 31, 2018, we were in compliance with all such covenants. The New Credit Agreement also contains customary events of default, including among other things non-payment defaults, covenant defaults, inaccuracy of representations and warranties, bankruptcy and insolvency defaults, material judgment defaults, ERISA defaults, cross-defaults to other indebtedness, invalidity of loan documents defaults, change in control defaults, conduct of business defaults, and criminal and regulatory action defaults. For additional information, please see "—Liquidity and Capital Resources" in Item 2. | [
{
"Currency / Unit": "pure",
"End character": 161,
"End date for period": "2017-04-30",
"Label": "intx:PercentageOfMinimumCashToBeMaintainedOnOutstandingTermLoan",
"Start character": 159,
"Start date for period": "2017-04-01",
"Value": 0.2
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | The repurchase was made pursuant to our previously announced share repurchase program. Following the repurchase, we have approximately $15.3 million remaining under our repurchase program. The repurchases may be made on the open market, in block trades, through privately negotiated transactions or otherwise, and the program may be suspended or discontinued at any time. However, we are currently prohibited from repurchasing any shares of common stock under the New Credit Agreement. | [
{
"Currency / Unit": "USD",
"End character": 140,
"End date for period": "2018-03-31",
"Label": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
"Start character": 136,
"Start date for period": "2018-03-31",
"Value": 15300000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | Our consolidated effective tax rate from continuing operations for the three months ended March 31, 2018 and 2017 was (41.1)% and 0.2%, respectively. The decrease in the rate is primarily due to the discrete resolution of uncertain tax positions related to claimed general business credits under audit that were deemed effectively settled in the three months ended March 31, 2018. | [
{
"Currency / Unit": "pure",
"End character": 123,
"End date for period": "2018-03-31",
"Label": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
"Start character": 119,
"Start date for period": "2018-01-01",
"Value": -0.41100000000000003
},
{
"Currency / Unit": "pure",
"End character": 133,
"End date for period": "2017-03-31",
"Label": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
"Start character": 130,
"Start date for period": "2017-01-01",
"Value": 0.002
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | As of March 31, 2018, there was $389 thousand of total unrecognized compensation cost related to unvested stock option arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.4 years. | [
{
"Currency / Unit": "USD",
"End character": 36,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"Start character": 33,
"Start date for period": "2018-03-31",
"Value": 389000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | Total share based compensation expense recognized for restricted stock units and restricted stock awards (together, "RSUs"), which is included in general and administrative expense in our condensed consolidated statements of operations, for the three months ended March 31, 2018 and 2017 was $274 thousand and $1.1 million, respectively. The decrease is due to reversing the cumulative expense on 535 thousand unvested RSUs granted to a former employee that were forfeited in the three months ended March 31, 2018. | [
{
"Currency / Unit": "USD",
"End character": 296,
"End date for period": "2018-03-31",
"Label": "us-gaap:AllocatedShareBasedCompensationExpense",
"Start character": 293,
"Start date for period": "2018-01-01",
"Value": 274000
},
{
"Currency / Unit": "USD",
"End character": 314,
"End date for period": "2017-03-31",
"Label": "us-gaap:AllocatedShareBasedCompensationExpense",
"Start character": 311,
"Start date for period": "2017-01-01",
"Value": 1100000
},
{
"Currency / Unit": "shares",
"End character": 400,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
"Start character": 397,
"Start date for period": "2018-01-01",
"Value": 535000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | Includes shares net-settled to cover statutory employee taxes related to the vesting of restricted stock awards, which increased treasury shares by 15 thousand and 8 thousand | [
{
"Currency / Unit": "shares",
"End character": 150,
"End date for period": "2018-03-31",
"Label": "intx:IncreaseDecreaseInTreasurySharesForIncomeTaxPurposes",
"Start character": 148,
"Start date for period": "2018-01-01",
"Value": 15000
},
{
"Currency / Unit": "shares",
"End character": 165,
"End date for period": "2017-03-31",
"Label": "intx:IncreaseDecreaseInTreasurySharesForIncomeTaxPurposes",
"Start character": 164,
"Start date for period": "2017-01-01",
"Value": 8000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | As of March 31, 2018, there was $4.6 million of total unrecognized compensation cost related to unvested RSUs granted under the plans. That cost is expected to be recognized over a weighted-average period of 1.4 years. | [
{
"Currency / Unit": "USD",
"End character": 36,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"Start character": 33,
"Start date for period": "2018-03-31",
"Value": 4600000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | – The chief executive officer and president of Digital Matrix Systems, Inc. ("DMS") serves as one of our board members. We have service agreements with DMS for monitoring credit on a daily and quarterly basis, along with occasional contracts for certain credit analysis and application development services. In connection with these agreements, we paid monthly installments totaling $696 thousand and $646 thousand in the three months ended March 31, 2018 and 2017, respectively. These amounts are included within cost of revenue and general and administrative expenses in our condensed consolidated statements of operations. As of March 31, 2018 and December 31, 2017, we owed $127 thousand and $178 thousand, respectively, to DMS under these agreements. | [
{
"Currency / Unit": "USD",
"End character": 387,
"End date for period": "2018-03-31",
"Label": "intx:PaymentOfMonthlyInstallmentsForMonitoringCreditAndOnlineCreditAnalysisServices",
"Start character": 384,
"Start date for period": "2018-01-01",
"Value": 696000
},
{
"Currency / Unit": "USD",
"End character": 405,
"End date for period": "2017-03-31",
"Label": "intx:PaymentOfMonthlyInstallmentsForMonitoringCreditAndOnlineCreditAnalysisServices",
"Start character": 402,
"Start date for period": "2017-01-01",
"Value": 646000
},
{
"Currency / Unit": "USD",
"End character": 682,
"End date for period": "2018-03-31",
"Label": "us-gaap:DueToRelatedPartiesCurrent",
"Start character": 679,
"Start date for period": "2018-03-31",
"Value": 127000
},
{
"Currency / Unit": "USD",
"End character": 700,
"End date for period": "2017-12-31",
"Label": "us-gaap:DueToRelatedPartiesCurrent",
"Start character": 697,
"Start date for period": "2017-12-31",
"Value": 178000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | , L.P. – During 2017, we refinanced our existing senior secured indebtedness under the Prior Credit Agreement with the New Credit Agreement with PEAK6 Investments. In connection with the New Credit Agreement, we paid PEAK6 Investments $1.5 million for the repurchase of common stock, and we received a total of $2.2 million for the issuance of the Warrant. In the three months ended March 31, 2018, we paid interest of $537 thousand. As of March 31, 2018 and December 31, 2017, our outstanding principal balance was $21.5 million. PEAK6 Investments owned approximately 419 thousand shares of our common stock immediately prior to the closing of the New Credit Agreement. For additional information, please see Note | [
{
"Currency / Unit": "USD",
"End character": 239,
"End date for period": "2017-04-20",
"Label": "us-gaap:PaymentsForRepurchaseOfCommonStock",
"Start character": 236,
"Start date for period": "2017-04-20",
"Value": 1500000
},
{
"Currency / Unit": "USD",
"End character": 315,
"End date for period": "2017-04-20",
"Label": "us-gaap:ProceedsFromIssuanceOfWarrants",
"Start character": 312,
"Start date for period": "2017-04-20",
"Value": 2200000
},
{
"Currency / Unit": "USD",
"End character": 423,
"End date for period": "2018-03-31",
"Label": "us-gaap:InterestExpenseRelatedParty",
"Start character": 420,
"Start date for period": "2018-01-01",
"Value": 537000
},
{
"Currency / Unit": "shares",
"End character": 572,
"End date for period": "2018-03-31",
"Label": "intx:RelatedPartyTransactionNumberofCompanySharesOwnedbyRelatedParty",
"Start character": 569,
"Start date for period": "2018-03-31",
"Value": 419000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | – On July 31, 2017, we entered into and consummated the divestiture of Voyce to One Health Group, LLC (the "Purchaser"), pursuant to the terms and conditions of a membership interest purchase agreement (the "Purchase Agreement") between our wholly owned subsidiary and the Purchaser. The purchase price for the Interests (the "Purchase Price") is equal to (i) the sum of one hundred dollars ($100), paid in cash at closing, plus (ii) a revenue participation of up to $20.0 million (the "Maximum Amount"), payable pursuant to the terms and conditions of the Purchase Agreement. | [
{
"Currency / Unit": "USD",
"End character": 396,
"End date for period": "2017-07-31",
"Label": "us-gaap:ProceedsFromDivestitureOfBusinesses",
"Start character": 393,
"Start date for period": "2017-07-31",
"Value": 100
},
{
"Currency / Unit": "USD",
"End character": 472,
"End date for period": "2017-07-31",
"Label": "intx:DisposalGroupRevenueParticipationLimit",
"Start character": 468,
"Start date for period": "2017-07-31",
"Value": 20000000
}
] |
10-Q | 0001628280-18-006561 | 2018-05-10T16:23:09+00:00 | 20180331 | INTERSECTIONS INC | We have ongoing operations in two segments: 1) Personal Information Services and 2) Insurance and Other Consumer Services. In January 2017 we sold the business comprising our Bail Bonds Industry Solutions segment, and in July 2017 we sold the business comprising our Pet Health Monitoring segment. For additional information, please see Note | [
{
"Currency / Unit": "intx:segment",
"End character": 33,
"End date for period": "2018-03-31",
"Label": "us-gaap:NumberOfReportableSegments",
"Start character": 30,
"Start date for period": "2018-01-01",
"Value": 2
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | Goodwill represents the cost of an acquisition in excess of the fair values assigned to identifiable net assets acquired. The Company recorded Goodwill of $307.4 million as part of the HomeLink | [
{
"Currency / Unit": "USD",
"End character": 162,
"End date for period": "2013-09-27",
"Label": "us-gaap:Goodwill",
"Start character": 157,
"Start date for period": "2013-09-27",
"Value": 307400000
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | Amortization expense on patents and intangible assets was approximately $5.7 million during the three month period ended March 31, 2018, compared to approximately $5.6 million for the same period ended March 31, 2017. | [
{
"Currency / Unit": "USD",
"End character": 76,
"End date for period": "2018-03-31",
"Label": "us-gaap:AmortizationOfIntangibleAssets",
"Start character": 73,
"Start date for period": "2018-01-01",
"Value": 5700000
},
{
"Currency / Unit": "USD",
"End character": 167,
"End date for period": "2017-03-31",
"Label": "us-gaap:AmortizationOfIntangibleAssets",
"Start character": 164,
"Start date for period": "2017-01-01",
"Value": 5600000
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | During the year ended December 31, 2017, the Company made technology investments in certain non-consolidated affiliates for ownership interests of less than 20%. These investments do not have readily determinable fair values, and the Company has not to date identified any observable events that would cause adjustment, and therefore these investments are held at cost at a total of $3.2 million as of March 31, 2018. These investments are classified within Long-Term Investments in the consolidated balance sheet. | [
{
"Currency / Unit": "pure",
"End character": 37,
"End date for period": "2017-12-31",
"Label": "gntx:CostMethodInvestmentOwnershipPercentage",
"Start character": 35,
"Start date for period": "2017-01-01",
"Value": 0.2
},
{
"Currency / Unit": "USD",
"End character": 388,
"End date for period": "2018-03-31",
"Label": "us-gaap:CostMethodInvestments",
"Start character": 385,
"Start date for period": "2018-03-31",
"Value": 3200000
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | As of March 31, 2018, the Company had four equity incentive plans which include two stock option plans, a restricted stock plan and an employee stock purchase plan. All plans and any prior material amendments thereto have previously been approved by shareholders. Readers should refer to | [
{
"Currency / Unit": "gntx:plan",
"End character": 42,
"End date for period": "2018-03-31",
"Label": "gntx:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans",
"Start character": 38,
"Start date for period": "2018-03-31",
"Value": 4
},
{
"Currency / Unit": "gntx:plan",
"End character": 83,
"End date for period": "2018-03-31",
"Label": "gntx:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans",
"Start character": 80,
"Start date for period": "2018-03-31",
"Value": 2
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | The Company recognized compensation expense for share-based payments of $3,901,316 for the three months ended March 31, 2018, and $3,484,240 for the three months ended March 31, 2017. Compensation cost for share based payment awards capitalized as part of inventory as of March 31, 2018 and March 31, 2017 was $258,651 and $226,119, respectively. | [
{
"Currency / Unit": "USD",
"End character": 82,
"End date for period": "2018-03-31",
"Label": "us-gaap:AllocatedShareBasedCompensationExpense",
"Start character": 73,
"Start date for period": "2018-01-01",
"Value": 3901316
},
{
"Currency / Unit": "USD",
"End character": 140,
"End date for period": "2017-03-31",
"Label": "us-gaap:AllocatedShareBasedCompensationExpense",
"Start character": 131,
"Start date for period": "2017-01-01",
"Value": 3484240
},
{
"Currency / Unit": "USD",
"End character": 320,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost",
"Start character": 313,
"Start date for period": "2018-01-01",
"Value": 258651
},
{
"Currency / Unit": "USD",
"End character": 333,
"End date for period": "2017-03-31",
"Label": "us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost",
"Start character": 326,
"Start date for period": "2017-01-01",
"Value": 226119
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | The Company has an employee stock option plan covering 24,000,000 shares of common stock. The purpose of the plan is to provide an opportunity to use stock options as a means of recruiting new managerial and technical personnel and as a means for retaining certain employees of the Company and allow them to purchase shares of common stock of the Corporation and thereby have an additional incentive to contribute to the prosperity of the Company. | [
{
"Currency / Unit": "shares",
"End character": 65,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
"Start character": 55,
"Start date for period": "2018-03-31",
"Value": 24000000
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | Under the employee stock option plan, the option exercise price equals the stock’s market price on date of grant. The options vest after one to five years, and expire after five to ten years. As of March 31, 2018, there was $10,686,587 of unrecognized compensation cost related to share-based payments which is expected to be recognized over the vesting periods. | [
{
"Currency / Unit": "USD",
"End character": 236,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"Start character": 226,
"Start date for period": "2018-03-31",
"Value": 10686587
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | The Company has a non-employee director stock option plan covering 1,000,000 shares of common stock. As of March 31, 2018, there was no unrecognized compensation cost under the non-employee director plan related to share-based payments. The Company has granted options on 427,000 shares under the non-employee director plan through March 31, 2018. Under the non-employee director plan, the option exercise price equals the stock’s market price on the date of grant. The options vest after six months, and expire after ten years. | [
{
"Currency / Unit": "shares",
"End character": 76,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
"Start character": 67,
"Start date for period": "2018-03-31",
"Value": 1000000
},
{
"Currency / Unit": "USD",
"End character": 136,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"Start character": 134,
"Start date for period": "2018-03-31",
"Value": 0
},
{
"Currency / Unit": "shares",
"End character": 280,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
"Start character": 273,
"Start date for period": "2018-01-01",
"Value": 427000
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | The Company has an employee stock purchase plan covering 2,000,000 shares of common stock. Under the plan, the Company sells shares at 85% of the stock’s market price at date of purchase. Under ASC 718, the 15% discounted value is recognized as compensation expense. As of March 31, 2018, the Company has granted 824,647 shares under this plan. | [
{
"Currency / Unit": "shares",
"End character": 66,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP",
"Start character": 57,
"Start date for period": "2018-03-31",
"Value": 2000000
},
{
"Currency / Unit": "pure",
"End character": 138,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
"Start character": 136,
"Start date for period": "2018-01-01",
"Value": 0.85
},
{
"Currency / Unit": "pure",
"End character": 210,
"End date for period": "2018-03-31",
"Label": "gntx:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountRecognizedAsCompensationExpense",
"Start character": 208,
"Start date for period": "2018-01-01",
"Value": 0.15
},
{
"Currency / Unit": "shares",
"End character": 323,
"End date for period": "2018-03-31",
"Label": "us-gaap:EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares",
"Start character": 316,
"Start date for period": "2018-03-31",
"Value": 824647
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | The Company has a restricted stock plan covering 9,000,000 shares of common stock. The purpose of the restricted stock plan is to permit grants of shares, subject to restrictions, to employees of the Company as a means of retaining and rewarding them for performance and to increase their ownership in the Company. Shares awarded under the restricted stock plan entitle the shareholder to all rights of common stock ownership except that the shares may not be sold, transferred, pledged, exchanged or otherwise disposed of during the restriction period. The restriction period is determined by the Compensation Committee, appointed by the Board of Directors, but may not exceed ten years under the terms of the plan. As of March 31, 2018, the Company had unearned stock-based compensation of $27,760,004 associated with these restricted stock grants. The unearned stock-based compensation related to these grants is being amortized to compensation expense over the applicable restriction periods. Amortization expense from restricted stock grants in the three months ended March 31, 2018 and 2017 was $1,643,060 and $940,811, respectively. | [
{
"Currency / Unit": "shares",
"End character": 58,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
"Start character": 49,
"Start date for period": "2018-03-31",
"Value": 9000000
},
{
"Currency / Unit": "USD",
"End character": 805,
"End date for period": "2018-03-31",
"Label": "us-gaap:DeferredCompensationEquity",
"Start character": 795,
"Start date for period": "2018-03-31",
"Value": 27760004
},
{
"Currency / Unit": "USD",
"End character": 1113,
"End date for period": "2018-03-31",
"Label": "us-gaap:RestrictedStockExpense",
"Start character": 1104,
"Start date for period": "2018-01-01",
"Value": 1643060
},
{
"Currency / Unit": "USD",
"End character": 1126,
"End date for period": "2017-03-31",
"Label": "us-gaap:RestrictedStockExpense",
"Start character": 1119,
"Start date for period": "2017-01-01",
"Value": 940811
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | Pursuant to the Credit Agreement, the Company is the borrower under a $150 million senior revolving credit facility (“Revolver”) and a $150 million term loan facility (“Term Loan”). Under the terms of the Credit Agreement, the Company is entitled, to further request an additional aggregate principal amount of up to $75 million, subject to the satisfaction of certain conditions. In addition, the Company is entitled to the benefit of swing loans from amounts otherwise available under the Revolver in the aggregate principal amount of up to $20 million and to request Letters of Credit from amounts otherwise available under the Revolver in the aggregate principle amount up to $20 million, both subject to certain conditions. The obligations of the Company under the Credit Agreement are not secured, but are subject to certain covenants. The Revolver expires and the Term Loan matures on September 27, 2018. | [
{
"Currency / Unit": "USD",
"End character": 74,
"End date for period": "2013-09-27",
"Label": "us-gaap:DebtInstrumentFaceAmount",
"Start character": 71,
"Start date for period": "2013-09-27",
"Value": 150000000
},
{
"Currency / Unit": "USD",
"End character": 139,
"End date for period": "2013-09-27",
"Label": "us-gaap:DebtInstrumentFaceAmount",
"Start character": 136,
"Start date for period": "2013-09-27",
"Value": 150000000
},
{
"Currency / Unit": "USD",
"End character": 320,
"End date for period": "2013-09-27",
"Label": "gntx:DebtInstrumentAdditionalBorrowingsAvailableFaceAmount",
"Start character": 318,
"Start date for period": "2013-09-27",
"Value": 75000000
},
{
"Currency / Unit": "USD",
"End character": 546,
"End date for period": "2013-09-27",
"Label": "gntx:DebtInstrumentAdditionalBorrowingsAvailableFaceAmount",
"Start character": 544,
"Start date for period": "2013-09-27",
"Value": 20000000
},
{
"Currency / Unit": "USD",
"End character": 683,
"End date for period": "2013-09-27",
"Label": "gntx:DebtInstrumentAdditionalBorrowingsAvailableFaceAmount",
"Start character": 681,
"Start date for period": "2013-09-27",
"Value": 20000000
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | During the three months ended March 31, 2018, the Company made principal repayments of $28.0 million, plus accrued interest, on the Term Loan and Revolver. The aforementioned payments include a payment made by the Company of $26.1 million on the Term Loan during the first quarter of 2018, which was in addition to scheduled amounts due. The Company used cash and cash equivalents to fund the payments. As of March 31, 2018, there was no outstanding balance on the Revolver. Under current terms of the Term Loan, the Company is required to make principal repayments of $7.5 million annually. As of March 31, 2018, $50.0 million was outstanding under the Term Loan. | [
{
"Currency / Unit": "USD",
"End character": 92,
"End date for period": "2018-03-31",
"Label": "us-gaap:ExtinguishmentOfDebtAmount",
"Start character": 88,
"Start date for period": "2018-01-01",
"Value": 28000000
},
{
"Currency / Unit": "USD",
"End character": 231,
"End date for period": "2018-03-31",
"Label": "us-gaap:ExtinguishmentOfDebtAmount",
"Start character": 227,
"Start date for period": "2018-01-01",
"Value": 26100000
},
{
"Currency / Unit": "USD",
"End character": 440,
"End date for period": "2018-03-31",
"Label": "us-gaap:LongTermDebt",
"Start character": 438,
"Start date for period": "2018-03-31",
"Value": 0
},
{
"Currency / Unit": "USD",
"End character": 578,
"End date for period": "2018-03-31",
"Label": "us-gaap:DebtInstrumentAnnualPrincipalPayment",
"Start character": 575,
"Start date for period": "2018-03-31",
"Value": 7500000
},
{
"Currency / Unit": "USD",
"End character": 625,
"End date for period": "2018-03-31",
"Label": "us-gaap:LongTermDebt",
"Start character": 621,
"Start date for period": "2018-03-31",
"Value": 50000000
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | As of March 31, 2018, the borrowing rate on both its Term Loan and Revolver are derived from the one month LIBOR, and based on the Company's leverage ratio as of March 31, 2018 the interest rate on its borrowings is equal to 2.88%. Interest expense is netted within the "Other, net" section of the Condensed Consolidated Statements of Income, and interest expense associated with the Term Loan and Revolver was $0.5 million during the three months ended March 31, 2018, and $0.9 million during the three months ended March 31, 2017, respectively. | [
{
"Currency / Unit": "pure",
"End character": 229,
"End date for period": "2018-03-31",
"Label": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
"Start character": 225,
"Start date for period": "2018-01-01",
"Value": 0.028800000000000003
},
{
"Currency / Unit": "USD",
"End character": 416,
"End date for period": "2018-03-31",
"Label": "us-gaap:PaymentsOfFinancingCosts",
"Start character": 413,
"Start date for period": "2018-01-01",
"Value": 500000
},
{
"Currency / Unit": "USD",
"End character": 479,
"End date for period": "2017-03-31",
"Label": "us-gaap:PaymentsOfFinancingCosts",
"Start character": 476,
"Start date for period": "2017-01-01",
"Value": 900000
}
] |
10-Q | 0000355811-18-000022 | 2018-05-04T12:17:22+00:00 | 20180331 | GENTEX CORP | The effective tax rate was 15.6% in the three months ended March 31, 2018 compared to 27.7% for the same period in 2017. Generally, effective tax rates for these periods differ from statutory federal income tax rates, due to provisions for state and local income taxes, permanent tax differences, and the foreign-derived intangible income tax deduction during the three month period ended March 31, 2018. The decrease in the effective tax rate for the three months ended March 31, 2018 compared to the same period of 2017 was due to the reduction of the federal income tax rate from 35% to 21% as a result of the Tax Cuts and Jobs Act ("Act"), as well as R&D tax credits, discrete tax benefits related to equity compensation, and the foreign-derived intangible income tax deduction. | [
{
"Currency / Unit": "pure",
"End character": 31,
"End date for period": "2018-03-31",
"Label": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
"Start character": 27,
"Start date for period": "2018-01-01",
"Value": 0.156
},
{
"Currency / Unit": "pure",
"End character": 90,
"End date for period": "2017-03-31",
"Label": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
"Start character": 86,
"Start date for period": "2017-01-01",
"Value": 0.277
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | As of March 31, 2018 and 2017, restricted stock awards and options to purchase 247,530 and 237,875 shares of common stock, respectively, were outstanding but were not included in the computation of diluted earnings per share because the effect would be antidilutive. | [
{
"Currency / Unit": "shares",
"End character": 86,
"End date for period": "2018-03-31",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 79,
"Start date for period": "2018-01-01",
"Value": 247530
},
{
"Currency / Unit": "shares",
"End character": 98,
"End date for period": "2017-03-31",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 91,
"Start date for period": "2017-01-01",
"Value": 237875
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | Cumberland supplies Perrigo Company (“Perrigo”) with an Authorized Generic version of the Company's Acetadote product. The Company's revenue generated by sales of its Authorized Generic distributed by Perrigo is included in the Acetadote product revenue presented above. The Company's share of Authorized Generic revenue was $0.8 million and $0.9 million for first quarter of 2018 and 2017, respectively. | [
{
"Currency / Unit": "USD",
"End character": 329,
"End date for period": "2018-03-31",
"Label": "us-gaap:SalesRevenueNet",
"Start character": 326,
"Start date for period": "2018-01-01",
"Value": 800000
},
{
"Currency / Unit": "USD",
"End character": 346,
"End date for period": "2017-03-31",
"Label": "us-gaap:SalesRevenueNet",
"Start character": 343,
"Start date for period": "2017-01-01",
"Value": 900000
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | The Company continually evaluates inventory for potential losses due to excess, obsolete or slow-moving inventory by comparing sales history and sales projections to the inventory on hand. When evidence indicates that the carrying value may not be recoverable, a charge is taken to reduce the inventory to its current net realizable value. At March 31, 2018 and December 31, 2017, the Company has recognized and maintained cumulative charges for potential obsolescence and discontinuance losses of approximately $0.1 million and $0.2 million, respectively. | [
{
"Currency / Unit": "USD",
"End character": 517,
"End date for period": "2018-03-31",
"Label": "us-gaap:InventoryValuationReserves",
"Start character": 514,
"Start date for period": "2018-03-31",
"Value": 100000
},
{
"Currency / Unit": "USD",
"End character": 534,
"End date for period": "2017-12-31",
"Label": "us-gaap:InventoryValuationReserves",
"Start character": 531,
"Start date for period": "2017-12-31",
"Value": 200000
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | The Company currently has a share repurchase program to repurchase up to $10 million of its common stock pursuant to Rule 10b-18 of the Securities Exchange Act of 1934. In January 2016, the Company's Board of Directors established the current $10 million repurchase program to replace the prior authorizations. During the three months ended March 31, 2018 and March 31, 2017, the Company repurchased 172,079 shares and 155,150 shares, respectively, of common stock for approximately $1.2 million and $1.0 million, respectively. | [
{
"Currency / Unit": "USD",
"End character": 76,
"End date for period": "2010-05-13",
"Label": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
"Start character": 74,
"Start date for period": "2010-05-13",
"Value": 10000000
},
{
"Currency / Unit": "USD",
"End character": 124,
"End date for period": "2010-05-13",
"Label": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
"Start character": 122,
"Start date for period": "2010-05-13",
"Value": 10000000
},
{
"Currency / Unit": "shares",
"End character": 408,
"End date for period": "2018-03-31",
"Label": "us-gaap:StockRepurchasedDuringPeriodShares",
"Start character": 401,
"Start date for period": "2018-01-01",
"Value": 172079
},
{
"Currency / Unit": "shares",
"End character": 427,
"End date for period": "2017-03-31",
"Label": "us-gaap:StockRepurchasedDuringPeriodShares",
"Start character": 420,
"Start date for period": "2017-01-01",
"Value": 155150
},
{
"Currency / Unit": "USD",
"End character": 488,
"End date for period": "2018-03-31",
"Label": "us-gaap:StockRepurchasedDuringPeriodValue",
"Start character": 485,
"Start date for period": "2018-01-01",
"Value": 1200000
},
{
"Currency / Unit": "USD",
"End character": 505,
"End date for period": "2017-03-31",
"Label": "us-gaap:StockRepurchasedDuringPeriodValue",
"Start character": 502,
"Start date for period": "2017-01-01",
"Value": 1000000
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | In November 2017, the Company filed a Shelf Registration on Form S-3 with the SEC associated with the sale of up to $100 million in corporate securities. The Shelf Registration was declared effective in January 2018. During the three months ended March 31, 2018, the Company issued 30,704 shares of common stock for gross proceeds of $0.2 million as part of its At-The-Market (“ATM”) sales agreement with B. Riley FBR. | [
{
"Currency / Unit": "USD",
"End character": 120,
"End date for period": "2017-11-30",
"Label": "cpix:StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleOfCorporateSecurities",
"Start character": 117,
"Start date for period": "2017-11-01",
"Value": 100000000
},
{
"Currency / Unit": "USD",
"End character": 339,
"End date for period": "2018-03-31",
"Label": "us-gaap:ProceedsFromIssuanceOfCommonStock",
"Start character": 336,
"Start date for period": "2018-01-01",
"Value": 200000
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | During the three months ended March 31, 2018, the Company issued 229,205 shares of restricted stock to employees and directors. Restricted stock issued to employees generally cliff-vests on the fourth anniversary of the date of grant and for directors on the one-year anniversary of the date of grant. Stock compensation expense is presented as a component of general and administrative expense in the condensed consolidated statements of operations and comprehensive income (loss). | [
{
"Currency / Unit": "shares",
"End character": 72,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
"Start character": 65,
"Start date for period": "2018-01-01",
"Value": 229205
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | On July 31, 2017, the Company entered into a Revolving Credit Loan Agreement with Pinnacle Bank ("Pinnacle Agreement"). The Pinnacle Agreement replaced the June 2014 Revolving Credit Loan Agreement with SunTrust Bank, which was to expire on June 30, 2018. The Company had $12.0 million in borrowings under that agreement at March 31, 2018. The Pinnacle Agreement provides for an aggregate principal amount of up to $20 million and has a three-year term expiring on July 31, 2020. The initial revolving line of credit is up to $12 million with the ability to increase the borrowing amount up to $20 million, upon the satisfaction of certain conditions. | [
{
"Currency / Unit": "USD",
"End character": 278,
"End date for period": "2018-03-31",
"Label": "us-gaap:LongTermLineOfCredit",
"Start character": 274,
"Start date for period": "2018-03-31",
"Value": 12000000
},
{
"Currency / Unit": "USD",
"End character": 338,
"End date for period": "2017-07-31",
"Label": "cpix:LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions",
"Start character": 336,
"Start date for period": "2017-07-31",
"Value": 20000000
},
{
"Currency / Unit": "USD",
"End character": 532,
"End date for period": "2017-07-31",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 530,
"Start date for period": "2017-07-31",
"Value": 12000000
},
{
"Currency / Unit": "USD",
"End character": 600,
"End date for period": "2017-07-31",
"Label": "cpix:LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions",
"Start character": 598,
"Start date for period": "2017-07-31",
"Value": 20000000
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | The interest rate on the Pinnacle Agreement is based on LIBOR plus an interest rate spread. There is no LIBOR minimum and the LIBOR pricing provides for an interest rate spread of 1.75% to 2.75% (representing an interest rate of 3.3% at March 31, 2018). In addition, a fee of 0.25% per year is charged on the unused line of credit. Interest and the unused line fee are payable quarterly. Borrowings under the line of credit are collateralized by substantially all of our assets. | [
{
"Currency / Unit": "pure",
"End character": 184,
"End date for period": "2017-07-31",
"Label": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
"Start character": 180,
"Start date for period": "2017-07-31",
"Value": 0.0175
},
{
"Currency / Unit": "pure",
"End character": 193,
"End date for period": "2017-07-31",
"Label": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
"Start character": 189,
"Start date for period": "2017-07-31",
"Value": 0.0275
},
{
"Currency / Unit": "pure",
"End character": 232,
"End date for period": "2018-03-31",
"Label": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
"Start character": 229,
"Start date for period": "2018-03-31",
"Value": 0.033
},
{
"Currency / Unit": "pure",
"End character": 281,
"End date for period": "2017-07-31",
"Label": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
"Start character": 277,
"Start date for period": "2017-07-31",
"Value": 0.0025
}
] |
10-Q | 0001628280-18-006417 | 2018-05-09T17:13:01+00:00 | 20180331 | CUMBERLAND PHARMACEUTICALS INC | In connection with our analysis of the impact of the Tax Act, we have a net tax benefit of $0.1 million of March 31, 2018. This net tax benefit consists entirely of the release of the valuation allowance against AMT credits that will be realizable under the Tax Act in future periods. While the Company does not expect to record further amounts related to the Tax Act, we will continue to evaluate additional guidance as it is released by the Internal Revenue Service and will record additional amounts if needed. | [
{
"Currency / Unit": "USD",
"End character": 95,
"End date for period": "2018-03-31",
"Label": "us-gaap:DeferredTaxAssetsLiabilitiesNet",
"Start character": 92,
"Start date for period": "2018-03-31",
"Value": 100000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | Generally, the multi-family properties are acquired with joint venture partners in transactions in which the Company contributes a significant portion of the equity. At June 30, 2018, the Company owns: (a) 36 multi-family properties with 10,121 units (including 402 units at a property under development), located in 11 states with a carrying value of $1,044,063,000; and (b) interests in three unconsolidated multi-family joint ventures with a carrying value of $20,328,000. | [
{
"Currency / Unit": "brt:property",
"End character": 209,
"End date for period": "2018-06-30",
"Label": "us-gaap:NumberOfRealEstateProperties",
"Start character": 207,
"Start date for period": "2018-06-30",
"Value": 36
},
{
"Currency / Unit": "brt:property_Unit",
"End character": 245,
"End date for period": "2018-06-30",
"Label": "us-gaap:NumberOfUnitsInRealEstateProperty",
"Start character": 239,
"Start date for period": "2018-06-30",
"Value": 10121
},
{
"Currency / Unit": "brt:property_Unit",
"End character": 266,
"End date for period": "2018-06-30",
"Label": "brt:NumberofUnitsinRealEstatePropertyUnderConstruction",
"Start character": 263,
"Start date for period": "2018-06-30",
"Value": 402
},
{
"Currency / Unit": "brt:state",
"End character": 320,
"End date for period": "2018-06-30",
"Label": "us-gaap:NumberOfStatesInWhichEntityOperates",
"Start character": 318,
"Start date for period": "2018-06-30",
"Value": 11
},
{
"Currency / Unit": "USD",
"End character": 367,
"End date for period": "2018-06-30",
"Label": "us-gaap:RealEstateInvestmentPropertyNet",
"Start character": 354,
"Start date for period": "2018-06-30",
"Value": 1044063000
},
{
"Currency / Unit": "brt:investment",
"End character": 395,
"End date for period": "2018-06-30",
"Label": "brt:EquityMethodInvestmentsNumberofInvestments",
"Start character": 390,
"Start date for period": "2018-06-30",
"Value": 3
},
{
"Currency / Unit": "USD",
"End character": 475,
"End date for period": "2018-06-30",
"Label": "us-gaap:EquityMethodInvestments",
"Start character": 465,
"Start date for period": "2018-06-30",
"Value": 20328000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | In January 2018, the Company entered into equity distribution agreements, which were amended in May 2018, with three sales agents to sell up to an aggregate of $30,000,000 of its common stock from time-to-time in an at-the-market offering. During the quarter ended June 30, 2018, the Company sold 835,374 shares of common stock for net proceeds of | [
{
"Currency / Unit": "USD",
"End character": 171,
"End date for period": "2018-01-31",
"Label": "brt:SaleofStockAmountAuthorizedToSellPerAgent",
"Start character": 161,
"Start date for period": "2018-01-31",
"Value": 30000000
},
{
"Currency / Unit": "shares",
"End character": 305,
"End date for period": "2018-06-30",
"Label": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
"Start character": 298,
"Start date for period": "2018-04-01",
"Value": 835374
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | $10,525,000, after giving effect to related fees and commissions of $218,000. Since the commencement of the at-the-market offering program through June 30, 2018, we sold 948,940 shares for an aggregate sales price of $12,237,000. From July 1, 2018 through August 2, 2018, the Company sold 558,777 shares of common stock for net proceeds of $7,437,000, after giving effect to related fees and commissions of $154,000. | [
{
"Currency / Unit": "USD",
"End character": 11,
"End date for period": "2018-06-30",
"Label": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
"Start character": 1,
"Start date for period": "2018-04-01",
"Value": 10525000
},
{
"Currency / Unit": "USD",
"End character": 76,
"End date for period": "2018-06-30",
"Label": "us-gaap:PaymentsForCommissions",
"Start character": 69,
"Start date for period": "2018-04-01",
"Value": 218000
},
{
"Currency / Unit": "shares",
"End character": 178,
"End date for period": "2018-06-30",
"Label": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
"Start character": 171,
"Start date for period": "2018-01-01",
"Value": 948940
},
{
"Currency / Unit": "USD",
"End character": 230,
"End date for period": "2018-06-30",
"Label": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
"Start character": 220,
"Start date for period": "2018-01-01",
"Value": 12237000
},
{
"Currency / Unit": "shares",
"End character": 299,
"End date for period": "2018-08-02",
"Label": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
"Start character": 292,
"Start date for period": "2018-07-01",
"Value": 558777
},
{
"Currency / Unit": "USD",
"End character": 353,
"End date for period": "2018-08-02",
"Label": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
"Start character": 344,
"Start date for period": "2018-07-01",
"Value": 7437000
},
{
"Currency / Unit": "USD",
"End character": 418,
"End date for period": "2018-08-02",
"Label": "us-gaap:PaymentsForCommissions",
"Start character": 411,
"Start date for period": "2018-07-01",
"Value": 154000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | The Company's Amended and Restated 2018 Incentive Plan (the "2018 Plan") permits the Company to grant: (i) stock options, restricted stock, restricted stock units, performance share awards and any one or more of the foregoing, up to a maximum of 600,000 | [
{
"Currency / Unit": "shares",
"End character": 253,
"End date for period": "2018-06-30",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
"Start character": 246,
"Start date for period": "2018-06-30",
"Value": 600000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | In March 2018, the Company granted 144,797 shares of restricted stock pursuant to the 2018 Incentive Plan. As of June 30, 2018 | [
{
"Currency / Unit": "shares",
"End character": 42,
"End date for period": "2018-03-31",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
"Start character": 35,
"Start date for period": "2018-03-01",
"Value": 144797
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | For the three months ended June 30, 2018 and 2017, the Company recorded $287,000 and $243,000, respectively, and for the nine months ended June 30, 2018 and 2017, the Company recorded $754,000 and $733,000, respectively, of compensation expense related to the amortization of unearned compensation with respect to the restricted stock awards. At June 30, 2018 and September 30, 2017 | [
{
"Currency / Unit": "USD",
"End character": 80,
"End date for period": "2018-06-30",
"Label": "us-gaap:AllocatedShareBasedCompensationExpense",
"Start character": 73,
"Start date for period": "2018-04-01",
"Value": 287000
},
{
"Currency / Unit": "USD",
"End character": 93,
"End date for period": "2017-06-30",
"Label": "us-gaap:AllocatedShareBasedCompensationExpense",
"Start character": 86,
"Start date for period": "2017-04-01",
"Value": 243000
},
{
"Currency / Unit": "USD",
"End character": 192,
"End date for period": "2018-06-30",
"Label": "us-gaap:AllocatedShareBasedCompensationExpense",
"Start character": 185,
"Start date for period": "2017-10-01",
"Value": 754000
},
{
"Currency / Unit": "USD",
"End character": 205,
"End date for period": "2017-06-30",
"Label": "us-gaap:AllocatedShareBasedCompensationExpense",
"Start character": 198,
"Start date for period": "2016-10-01",
"Value": 733000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | $3,313,000 and $2,356,000 has been deferred as unearned compensation and will be charged to expense over the remaining vesting periods of these restricted stock awards. The weighted average remaining vesting period of these shares of restricted stock is 2.6 years. | [
{
"Currency / Unit": "USD",
"End character": 10,
"End date for period": "2018-06-30",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
"Start character": 1,
"Start date for period": "2018-06-30",
"Value": 3313000
},
{
"Currency / Unit": "USD",
"End character": 25,
"End date for period": "2017-09-30",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
"Start character": 16,
"Start date for period": "2017-09-30",
"Value": 2356000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | On September 5, 2017, the Board of Directors approved a repurchase plan authorizing the Company, effective as of October 1, 2017, to repurchase up to $5,000,000 of shares of common stock through September 30, 2019. No shares have been repurchased pursuant to this plan. | [
{
"Currency / Unit": "USD",
"End character": 160,
"End date for period": "2017-09-05",
"Label": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
"Start character": 151,
"Start date for period": "2017-09-05",
"Value": 5000000
},
{
"Currency / Unit": "shares",
"End character": 218,
"End date for period": "2018-06-30",
"Label": "us-gaap:TreasuryStockSharesAcquired",
"Start character": 216,
"Start date for period": "2017-10-01",
"Value": 0
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | For the three months ended June 30, 2018, no shares were included as their effect would have been anti-dilutive. | [
{
"Currency / Unit": "shares",
"End character": 44,
"End date for period": "2018-06-30",
"Label": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
"Start character": 42,
"Start date for period": "2018-04-01",
"Value": 0
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | As result of the damage caused by Hurricane Harvey in 2017, the Company reduced the carrying value of Retreat at Cinco Ranch, located in Katy, TX by $3,471,000 and, because the Company believed it was probable that it would recover such sum from its insurance coverage, recorded a receivable for the same amount. Through June 30, 2018 | [
{
"Currency / Unit": "USD",
"End character": 159,
"End date for period": "2017-09-30",
"Label": "us-gaap:GainLossOnDispositionOfAssets1",
"Start character": 150,
"Start date for period": "2016-10-01",
"Value": -3471000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | The Company has construction loans financing two separate construction projects. Information regarding these loans at June 30, 2018 is set forth below (dollars in thousand): | [
{
"Currency / Unit": "brt:property",
"End character": 48,
"End date for period": "2018-06-30",
"Label": "brt:NumberofConstructionProjectstobeFinanced",
"Start character": 45,
"Start date for period": "2018-06-30",
"Value": 2
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | At June 30, 2018, and September 30, 2017, the Company's junior subordinated notes had an outstanding principal balance of $37,400,000, before deferred financing costs of $367,000 and $382,000, respectively. At June 30, 2018, the interest rate on the outstanding balance is three month LIBOR + 2.00% or 4.36%. | [
{
"Currency / Unit": "USD",
"End character": 178,
"End date for period": "2018-06-30",
"Label": "us-gaap:DeferredFinanceCostsNet",
"Start character": 171,
"Start date for period": "2018-06-30",
"Value": 367000
},
{
"Currency / Unit": "USD",
"End character": 191,
"End date for period": "2017-09-30",
"Label": "us-gaap:DeferredFinanceCostsNet",
"Start character": 184,
"Start date for period": "2017-09-30",
"Value": 382000
},
{
"Currency / Unit": "pure",
"End character": 298,
"End date for period": "2018-06-30",
"Label": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
"Start character": 294,
"Start date for period": "2017-10-01",
"Value": 0.02
},
{
"Currency / Unit": "pure",
"End character": 307,
"End date for period": "2018-06-30",
"Label": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
"Start character": 303,
"Start date for period": "2018-06-30",
"Value": 0.0436
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | The junior subordinated notes require interest only payments through the maturity date of April 30, 2036, at which time repayment of the outstanding principal and unpaid interest become due. Interest expense for the three months ended June 30, 2018 and 2017, which includes amortization of deferred costs, was $386,000 and $300,000, respectively, and for the nine months ended June 30, 2018 and 2017, was $1,058,000 and $862,000, respectively. | [
{
"Currency / Unit": "USD",
"End character": 319,
"End date for period": "2018-06-30",
"Label": "us-gaap:InterestExpenseDebt",
"Start character": 312,
"Start date for period": "2018-04-01",
"Value": 386000
},
{
"Currency / Unit": "USD",
"End character": 332,
"End date for period": "2017-06-30",
"Label": "us-gaap:InterestExpenseDebt",
"Start character": 325,
"Start date for period": "2017-04-01",
"Value": 300000
},
{
"Currency / Unit": "USD",
"End character": 416,
"End date for period": "2018-06-30",
"Label": "us-gaap:InterestExpenseDebt",
"Start character": 407,
"Start date for period": "2017-10-01",
"Value": 1058000
},
{
"Currency / Unit": "USD",
"End character": 429,
"End date for period": "2017-06-30",
"Label": "us-gaap:InterestExpenseDebt",
"Start character": 422,
"Start date for period": "2016-10-01",
"Value": 862000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | The Company has retained certain of its executive officers and Fredric H. Gould, a director, to provide, among other things, the following services: participating in the Company's multi-family property analysis and approval process (which includes service on the investment committee), providing investment advice, long-term planning and consulting with executives and employees with respect to other business matters, as required. The aggregate fees paid for these services in the three months ended June 30, 2018 and 2017 were $317,000 and $302,000, respectively, and for the nine months ended June 30, 2018 and 2017 were $936,000 and $891,000, respectively. | [
{
"Currency / Unit": "USD",
"End character": 538,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 531,
"Start date for period": "2018-04-01",
"Value": 317000
},
{
"Currency / Unit": "USD",
"End character": 551,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 544,
"Start date for period": "2017-04-01",
"Value": 302000
},
{
"Currency / Unit": "USD",
"End character": 633,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 626,
"Start date for period": "2017-10-01",
"Value": 936000
},
{
"Currency / Unit": "USD",
"End character": 646,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 639,
"Start date for period": "2016-10-01",
"Value": 891000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | Management of certain properties owned by the Company and certain joint venture properties is provided by Majestic Property Management Corp. ("Majestic Property"), a company wholly owned by Fredric H. Gould, under renewable year-to-year agreements. Certain of the Company's officers and directors are also officers and directors of Majestic Property. Majestic Property may also provide real estate brokerage and construction supervision services to these properties. These fees amounted to $6,000 and $9,000 for the three months ended June 30, 2018 and 2017, respectively, and for the nine months ended June 30, 2018 and 2017, were $25,000 and $25,000, respectively. | [
{
"Currency / Unit": "USD",
"End character": 501,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 496,
"Start date for period": "2018-04-01",
"Value": 6000
},
{
"Currency / Unit": "USD",
"End character": 512,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 507,
"Start date for period": "2017-04-01",
"Value": 9000
},
{
"Currency / Unit": "USD",
"End character": 644,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 638,
"Start date for period": "2017-10-01",
"Value": 25000
},
{
"Currency / Unit": "USD",
"End character": 656,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 650,
"Start date for period": "2017-10-01",
"Value": 25000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | The Company shares facilities, personnel and other resources with One Liberty Properties, Inc., Majestic Property, and Gould Investors L.P. Certain of our executive officers and/or directors also serve in management positions, and have ownership interests, in One Liberty, Majestic Property and/or Georgetown Partners Inc., the managing partner of Gould Investors L.P. The allocation of expenses for the facilities, personnel and other resources shared by the Company, One Liberty, Majestic Property and Gould Investors is computed in accordance with a shared services agreement by and among the Company and these entities and is included in general and administrative expense on the consolidated statements of operations. For the three months ended June 30, 2018 and 2017, net allocated general and administrative expenses reimbursed by the Company to Gould Investors L.P. pursuant to the shared services agreement aggregated $160,000 and $84,000, respectively, and for the nine months ended June 30, 2018 and 2017 were $388,000 and $266,000, respectively. | [
{
"Currency / Unit": "USD",
"End character": 939,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
"Start character": 932,
"Start date for period": "2018-04-01",
"Value": 160000
},
{
"Currency / Unit": "USD",
"End character": 951,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
"Start character": 945,
"Start date for period": "2017-04-01",
"Value": 84000
},
{
"Currency / Unit": "USD",
"End character": 1033,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
"Start character": 1026,
"Start date for period": "2017-10-01",
"Value": 388000
},
{
"Currency / Unit": "USD",
"End character": 1046,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
"Start character": 1039,
"Start date for period": "2016-10-01",
"Value": 266000
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | Junior subordinated notes: At June 30, 2018 and September 30, 2017, the estimated fair value of the notes is lower than their carrying value by approximately $12,608,000 and $15,705,000 based on a market interest rate of 7.33% and 6.37%, respectively. | [
{
"Currency / Unit": "USD",
"End character": 171,
"End date for period": "2018-06-30",
"Label": "us-gaap:LiabilitiesFairValueAdjustment",
"Start character": 161,
"Start date for period": "2017-10-01",
"Value": 12608000
},
{
"Currency / Unit": "USD",
"End character": 187,
"End date for period": "2017-09-30",
"Label": "us-gaap:LiabilitiesFairValueAdjustment",
"Start character": 177,
"Start date for period": "2016-10-01",
"Value": 15705000
},
{
"Currency / Unit": "pure",
"End character": 227,
"End date for period": "2018-06-30",
"Label": "brt:FairValueInputsDebtInstrumentMarketFixedInterestRate",
"Start character": 223,
"Start date for period": "2017-10-01",
"Value": 0.0733
},
{
"Currency / Unit": "pure",
"End character": 237,
"End date for period": "2017-09-30",
"Label": "brt:FairValueInputsDebtInstrumentMarketFixedInterestRate",
"Start character": 233,
"Start date for period": "2016-10-01",
"Value": 0.0637
}
] |
10-Q | 0000014846-18-000033 | 2018-08-08T16:41:28+00:00 | 20180630 | BRT Apartments Corp. | Mortgages payable: At June 30, 2018, the estimated fair value of the Company’s mortgages payable is lower than their carrying value by approximately $27,252,000, assuming market interest rates between 4.10% and 5.83% and at September 30, 2017, the estimated fair value of the Company's mortgages payable was lower than their carrying value by approximately $11,400,000 assuming market interest rates between 3.78% and 5.02%. Market interest rates were determined using rates which the Company believes reflects institutional lender yield requirements at the balance sheet dates. | [
{
"Currency / Unit": "USD",
"End character": 161,
"End date for period": "2018-06-30",
"Label": "us-gaap:LiabilitiesFairValueAdjustment",
"Start character": 151,
"Start date for period": "2017-10-01",
"Value": 27252000
},
{
"Currency / Unit": "pure",
"End character": 206,
"End date for period": "2018-06-30",
"Label": "brt:FairValueInputsDebtInstrumentMarketFixedInterestRate",
"Start character": 202,
"Start date for period": "2017-10-01",
"Value": 0.041
},
{
"Currency / Unit": "pure",
"End character": 216,
"End date for period": "2018-06-30",
"Label": "brt:FairValueInputsDebtInstrumentMarketFixedInterestRate",
"Start character": 212,
"Start date for period": "2017-10-01",
"Value": 0.058300000000000005
},
{
"Currency / Unit": "USD",
"End character": 369,
"End date for period": "2017-09-30",
"Label": "us-gaap:LiabilitiesFairValueAdjustment",
"Start character": 359,
"Start date for period": "2016-10-01",
"Value": 11400000
},
{
"Currency / Unit": "pure",
"End character": 413,
"End date for period": "2017-09-30",
"Label": "brt:FairValueInputsDebtInstrumentMarketFixedInterestRate",
"Start character": 409,
"Start date for period": "2016-10-01",
"Value": 0.0378
},
{
"Currency / Unit": "pure",
"End character": 423,
"End date for period": "2017-09-30",
"Label": "brt:FairValueInputsDebtInstrumentMarketFixedInterestRate",
"Start character": 419,
"Start date for period": "2016-10-01",
"Value": 0.0502
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As of August 3, 2018, the registrant had 34,256,765 shares of Class A common stock outstanding and 105,816,629 shares of Class B common stock outstanding. | [
{
"Currency / Unit": "shares",
"End character": 51,
"End date for period": "2018-08-03",
"Label": "dei:EntityCommonStockSharesOutstanding",
"Start character": 41,
"Start date for period": "2018-08-03",
"Value": 34256765
},
{
"Currency / Unit": "shares",
"End character": 110,
"End date for period": "2018-08-03",
"Label": "dei:EntityCommonStockSharesOutstanding",
"Start character": 99,
"Start date for period": "2018-08-03",
"Value": 105816629
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | • Carvana Group converted its outstanding Class C Redeemable Preferred Units into approximately 43.1 million Class A Units; | [
{
"Currency / Unit": "shares",
"End character": 103,
"End date for period": "2017-05-03",
"Label": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion",
"Start character": 99,
"Start date for period": "2017-05-03",
"Value": 43100000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | • Carvana Co. issued approximately 117.2 million shares of Class B common stock to holders of Class A Units, on a four-to-five basis with the number of Class A Units they owned, for nominal consideration; and, | [
{
"Currency / Unit": "shares",
"End character": 43,
"End date for period": "2017-05-03",
"Label": "us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits",
"Start character": 38,
"Start date for period": "2017-05-03",
"Value": 117200000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | • Carvana Co. transferred approximately 0.2 million Class A Units to Ernest Garcia, II in exchange for his 0.1% ownership interest in Carvana, LLC, a majority-owned subsidiary of Carvana Group. | [
{
"Currency / Unit": "shares",
"End character": 46,
"End date for period": "2017-05-03",
"Label": "us-gaap:InvestmentOwnedBalanceShares",
"Start character": 43,
"Start date for period": "2017-05-03",
"Value": 200000
},
{
"Currency / Unit": "pure",
"End character": 113,
"End date for period": "2017-05-03",
"Label": "us-gaap:NoncashOrPartNoncashAcquisitionInterestAcquired1",
"Start character": 110,
"Start date for period": "2017-05-03",
"Value": 0.001
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | In accordance with the LLC Agreement, Carvana Co. has all management powers over the business and affairs of Carvana Group and conducts, directs and exercises full control over the activities of Carvana Group. Class A Units and Class B Units (the "LLC Units") do not hold voting rights, which results in Carvana Group being considered a variable interest entity ("VIE"). Due to Carvana Co.'s power to control and its significant economic interest in Carvana Group, it is considered the primary beneficiary of the VIE and the Company consolidates the financial results of Carvana Group. As of June 30, 2018, Carvana Co. owned approximately 23.4% of Carvana Group and the LLC Unitholders owned the remaining 76.6%. | [
{
"Currency / Unit": "pure",
"End character": 643,
"End date for period": "2018-06-30",
"Label": "us-gaap:MinorityInterestOwnershipPercentageByParent",
"Start character": 639,
"Start date for period": "2018-06-30",
"Value": 0.234
},
{
"Currency / Unit": "pure",
"End character": 710,
"End date for period": "2018-06-30",
"Label": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners",
"Start character": 706,
"Start date for period": "2018-06-30",
"Value": 0.766
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | A holder of Class A common stock (the "Selling Stockholder") and certain LLC Unitholders (the "Selling LLC Unitholders") sold a total of approximately 6.1 million shares of Class A common stock as part of the offering. The Selling LLC Unitholders exchanged approximately 6.9 million LLC Units for approximately 5.6 million shares of Class A common stock to be sold in the offering, and to the extent such Selling LLC Unitholder held Class B common stock, the corresponding shares of Class B common stock were immediately retired by the Company. The Company did not receive any proceeds from the sale of the approximately 6.1 million shares of Class A common stock by the Selling Stockholder and the Selling LLC Unitholders. | [
{
"Currency / Unit": "shares",
"End character": 154,
"End date for period": "2018-04-30",
"Label": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
"Start character": 151,
"Start date for period": "2018-04-30",
"Value": 6100000
},
{
"Currency / Unit": "shares",
"End character": 274,
"End date for period": "2018-04-30",
"Label": "us-gaap:ConversionOfStockSharesConverted1",
"Start character": 271,
"Start date for period": "2018-04-30",
"Value": 6900000
},
{
"Currency / Unit": "shares",
"End character": 314,
"End date for period": "2018-04-30",
"Label": "us-gaap:ConversionOfStockSharesIssued1",
"Start character": 311,
"Start date for period": "2018-04-30",
"Value": 5600000
},
{
"Currency / Unit": "shares",
"End character": 624,
"End date for period": "2018-04-30",
"Label": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
"Start character": 621,
"Start date for period": "2018-04-30",
"Value": 6100000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Business segments are defined as components of an enterprise about which discrete financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing operating performance. Based on the way the Company manages its business, the Company has determined that it currently operates with one reportable segment. The chief operating decision maker focuses on consolidated results in assessing operating performance and allocating resources. Furthermore, the Company offers similar products and services and uses similar | [
{
"Currency / Unit": "cvna:segment",
"End character": 40,
"End date for period": "2018-06-30",
"Label": "us-gaap:NumberOfReportableSegments",
"Start character": 37,
"Start date for period": "2018-01-01",
"Value": 1
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As discussed above, the Company adopted ASC 606 on January 1, 2018 using the modified retrospective method. ASC 606 requires the reserve for vehicle inventory returns to be presented separately from vehicle inventory, where the Company previously presented it. As of December 31, 2017, the reserve for estimated returns included within vehicle inventory was approximately $2.6 million. As of June 30, 2018, the reserve for estimated returns included within other current assets was approximately $4.6 million. Furthermore, based on the manner in which the Company recognizes revenue, the adoption of ASC 606 did not have a material impact on the amount or timing of its revenue recognition and the Company recognized no cumulative effect adjustment upon adoption. | [
{
"Currency / Unit": "USD",
"End character": 377,
"End date for period": "2017-12-31",
"Label": "us-gaap:InventoryValuationReserves",
"Start character": 374,
"Start date for period": "2017-12-31",
"Value": 2600000
},
{
"Currency / Unit": "USD",
"End character": 502,
"End date for period": "2018-06-30",
"Label": "us-gaap:InventoryValuationReserves",
"Start character": 499,
"Start date for period": "2018-06-30",
"Value": 4600000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | (“ASU 2016-18”), which requires the statement of cash flows to include restricted cash with its cash and cash equivalents balance and a reconciliation between all cash items on the balance sheet and the balance presented in the statement of cash flows. In addition, changes in restricted cash related to transfers between cash and cash equivalents and restricted cash will not be presented as cash flow activities in the statement of cash flows. The Company adopted ASU 2016-18 on January 1, 2018 on a retrospective basis. As a result, changes in restricted cash are no longer presented as investing cash flow activities and the restricted cash balance is included with cash and cash equivalents in the beginning and end of period balances on the Company's consolidated statements of cash flows for all periods presented. For the six months ended June 30, 2017, changes in restricted cash included within cash used in investing activities, as originally presented, was approximately $0.1 million. | [
{
"Currency / Unit": "USD",
"End character": 987,
"End date for period": "2017-06-30",
"Label": "us-gaap:IncreaseDecreaseInRestrictedCash",
"Start character": 984,
"Start date for period": "2017-01-01",
"Value": 100000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Depreciation and amortization expense on property and equipment was approximately $4.9 million and $2.6 million for the three months ended June 30, 2018 and 2017, respectively, and approximately $9.5 million and $4.6 million for the six months ended June 30, 2018 and 2017, respectively. These amounts primarily relate to selling, general and administrative activities and are included as a component of selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations. | [
{
"Currency / Unit": "USD",
"End character": 86,
"End date for period": "2018-06-30",
"Label": "cvna:DepreciationandAmortizationExcludingDebtIssuanceCosts",
"Start character": 83,
"Start date for period": "2018-04-01",
"Value": 4900000
},
{
"Currency / Unit": "USD",
"End character": 103,
"End date for period": "2017-06-30",
"Label": "cvna:DepreciationandAmortizationExcludingDebtIssuanceCosts",
"Start character": 100,
"Start date for period": "2017-04-01",
"Value": 2600000
},
{
"Currency / Unit": "USD",
"End character": 199,
"End date for period": "2018-06-30",
"Label": "cvna:DepreciationandAmortizationExcludingDebtIssuanceCosts",
"Start character": 196,
"Start date for period": "2018-01-01",
"Value": 9500000
},
{
"Currency / Unit": "USD",
"End character": 216,
"End date for period": "2017-06-30",
"Label": "cvna:DepreciationandAmortizationExcludingDebtIssuanceCosts",
"Start character": 213,
"Start date for period": "2017-01-01",
"Value": 4600000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | The purchase price was allocated to net tangible assets of approximately $0.2 million and intangible assets of approximately $9.9 million based on their fair values on the acquisition date. The excess of the purchase price over the amounts allocated to assets acquired and liabilities assumed was $6.9 million, which has been recorded as goodwill. | [
{
"Currency / Unit": "USD",
"End character": 77,
"End date for period": "2018-04-12",
"Label": "cvna:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets",
"Start character": 74,
"Start date for period": "2018-04-12",
"Value": 200000
},
{
"Currency / Unit": "USD",
"End character": 129,
"End date for period": "2018-04-12",
"Label": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
"Start character": 126,
"Start date for period": "2018-04-12",
"Value": 9900000
},
{
"Currency / Unit": "USD",
"End character": 302,
"End date for period": "2018-04-12",
"Label": "us-gaap:Goodwill",
"Start character": 299,
"Start date for period": "2018-04-12",
"Value": 6900000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | In November 2014, the Company and DriveTime entered into a lease agreement that governs the Company’s access to and utilization of temporary storage, reconditioning, offices and parking space at various DriveTime inspection and reconditioning centers ("IRCs") and retail facilities (the "DriveTime Lease Agreement"). The DriveTime Lease Agreement was most recently amended in March 2018. Lease duration varies by location, with initial terms expiring between 2018 and 2024. Most of the retail facilities have two-year terms and the Company is entitled to exercise up to two consecutive one-year renewal options at up to ten of these locations. | [
{
"Currency / Unit": "cvna:renewal_option",
"End character": 512,
"End date for period": "2014-11-30",
"Label": "cvna:LesseeOperatingLeaseNumberOfRenewalOptions",
"Start character": 509,
"Start date for period": "2014-11-01",
"Value": 2
},
{
"Currency / Unit": "cvna:location",
"End character": 623,
"End date for period": "2014-11-30",
"Label": "cvna:LesseeOperatingLeaseRenewalOptionsNumberofLocations",
"Start character": 620,
"Start date for period": "2014-11-01",
"Value": 10
}
] |
Subsets and Splits
Transform Dates and Entities
Transforms and standardizes the filing and quarter dates, and the dates within entities, making the data more uniform and easier to analyze for temporal patterns and trends.
Top Entities by Count
Discovers the most frequently occurring entities and their associated currency units, providing insights into prominent mentions and economic contexts.
Stock Repurchase Program Data
Extracts key details about stock repurchase program authorizations, grouped by date, CIK, and filing timestamp, providing a structured look at these financial events.
Top Entity Labels Count
Counts the occurrences of each entity label in the dataset, providing insight into the distribution of labeled entities.
Formatted Financial Data Extract
The query performs some basic data cleaning and transformation, specifically converting date formats, but the results are limited and do not provide deep analytical insights or reveal meaningful patterns.